Noncolorectal Gastrointestinal Cancer Journal Articles

• Liver Transplantation for Hepatocellular Carcinoma This article presents a comprehensive review of current knowledge regarding the posttransplant management of patients with hepatocellular carcinoma.
  American Journal of Transplantation, February 26, 2020
• Sofosbuvir/Ledipasvir for HCV in Children Aged 3-6 Years The use of interferon-based regimens in chronic hepatitis C-infected children 3-6 years of age is limited due to side effects. Does sofosbuvir/ledipasvir therapy provide a safe alternative?
  Liver International, February 25, 2020
• HCV Eradication With DAAs Reduces Variceal Bleeding Risk This study found that DAA-induced SVR in patients with hepatitis C is associated with a reduced risk of variceal bleeding, among both patients with and without established cirrhosis.
  Alimentary Pharmacology & Therapeutics, February 19, 2020
• Obesity and Liver Markers in Children and Adolescents In what ways might obesity impact liver enzyme concentrations in the pediatric population?
  Journal of Clinical Endocrinology & Metabolism, February 19, 2020
• Impact of Delaying DAA Treatment for Chronic Hepatitis C What is the impact of delaying treatment for different populations of people living with hepatitis C? The authors present a clinical decision tool for informing treatment timing decisions.
  Liver International, February 18, 2020
• Gut Microbiota Dysbiosis in HBV-induced Chronic Liver Disease Using a gene sequencing approach, this study examined the gut microbiota profile of patients with hepatitis B virus-induced chronic liver disease compared with healthy controls.
  Journal of Viral Hepatitis, February 18, 2020
• Cancer Cachexia: A Multifactoral Disease Cancer cachexia is a complex condition with multifactorial etiologies, which should optimally be managed by a multidisciplinary team that includes an oncologist, pharmacist, and oncology dietitian.
  Current Opinion in Gastroenterology, February 13, 2020
• Applying Guidelines for NAFLD in HIV-Monoinfected Patients Current guidelines recommend the use of a diagnostic algorithm to screen for NAFLD. Could these guidelines also be applied to HIV-monoinfected patients?
  HIV Medicine, February 12, 2020
• HCV Eradication With DAA Improves Insulin Resistance This study aimed to assess whether SVR after direct-acting antivirals could improve the degree of insulin resistance in HCV-infected patients, including those with cirrhosis.
  Journal of Viral Hepatitis, February 11, 2020
• Liver Transplant for Hepatocellular Carcinoma in the U.S. How have the patterns and outcomes for HCC-related liver transplants evolved over the last thirty years? A new study examines the trends.
  American Journal of Transplantation, February 03, 2020
• Effectiveness of DAA Treatment for HCV in Patients With HCC Is virologic reponse to direct-acting antivirals as robust in HCV patients with hepatocellular carcinoma as in those without?
  Alimentary Pharmacology & Therapeutics, January 29, 2020
• New Therapeutic Interventions for Advanced HCC This article reviews the latest clinical trials on current and emerging first-line and second-line therapeutic options available for patients with advanced hepatocellular carcinoma.
  Alimentary Pharmacology & Therapeutics, January 27, 2020
• Diagnosis of Congenital Hepatic Fibrosis in Adulthood This study highlights the importance of a multidisciplinary diagnostic approach by pathologists, radiologists, and hepatologists for the accurate diagnosis of congenital hepatic fibrosis in adulthood.
  American Journal of Clinical Pathology, January 21, 2020
• Cost-effectiveness of HCV Testing in Community Pharmacies Is pharmacy-based targeted testing for HCV a cost-effective approach?
  Journal of Viral Hepatitis, January 20, 2020
• Impact of Antibiotics on Outcomes in Cancer Patients on IO What impact do antibiotic-related changes of the gut microbiome have on efficacy of immune-checkpoint inhibitors?
  Annals of Oncology, January 20, 2020
• Coblopasvir and Sofosbuvir in Patients With HCV Infection This study investigated the safety and efficacy of coblopasvir plus sofosbuvir in a broad range of HCV infections, including those with compensated cirrhosis.
  Journal of Viral Hepatitis, January 13, 2020
• Costs Associated With Surgery in the Medicare Population An analysis of the costs associated with surgical care delivery among Medicare beneficiaries highlights potential opportunities to reduce spending.
  Annals of Surgery, January 09, 2020
• HCV Retreatment With SOF/ELB/GZR +/- RBV After Relapse This study examined the safety and efficacy of an alternate retreatment regimen in HCV patients who do not respond to first-line therapy, including those with difficult-to-treat HCV GT3 infection.
  Liver International, January 07, 2020
• HBV and HCV Infection and Risk of Hematological Malignancies This article reviews the oncogenic mechanisms of HCV and HBV, and examines the impact and the safety of antiviral treatment in patients with hematological malignancies.
  Journal of Viral Hepatitis, January 06, 2020
• Systemic Therapy of Gallbladder Cancer Which gemcitabine-containing regimens offer the best survival advantage in treatment of gallbladder cancer?
  Chinese Clinical Oncology, January 03, 2020